Cannabidiol protects an in vitro model of the blood–brain barrier from oxygen‐glucose deprivation via PPARγ and 5‐HT1A receptors
British Journal of Pharmacology2015Vol. 173(5), pp. 815–825
Citations Over TimeTop 10% of 2015 papers
Abstract
These data suggest that preventing permeability changes at the BBB could represent an as yet unrecognized mechanism of CBD-induced neuroprotection in ischaemic stroke, a mechanism mediated by activation of PPARγ and 5-HT1A receptors.
Related Papers
- → Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis(2008)302 cited
- → (+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only(2004)59 cited
- → Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism(2004)59 cited
- → Chemical Composition and In Vitro Neuroprotective Activity of Fibre-Type Cannabis sativa L. (Hemp)(2018)22 cited
- → 6ʺ-Azidohex-2ʺ-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist(2004)76 cited